Clinical Trials Head and Neck John Stoddard Cancer Center

UnityPoint Clinic Urgent Care - Altoona

02 Patients
Waiting Now

UnityPoint Clinic Urgent Care - Ingersoll

01 Patients
Waiting Now

Urgent Care - Ankeny

00 Patients
Waiting Now

Urgent Care - Lakeview

05 Patients
Waiting Now

Urgent Care - Merle Hay

04 Patients
Waiting Now

Urgent Care - Southglen

06 Patients
Waiting Now

Urgent Care - Urbandale

02 Patients
Waiting Now

Virtual Care - Receive Care Now

X Wait Times

Head and Neck Research Studies

NASOPHARYNGEAL
HN001: Randomized Phase II and Phase III Studies of Individualized for Nasopharyngeal Carcinoma Base on Biomarker Epstein Barr Virus (EBV) Deoxyriboncleic Acid (DNA).

HIGH-RISK SQUAMOUS CELL

HN003: A Phase I and Expansion Cohort Study of Adjuvant Cisplatin, Intensity-Modulated Radiotherapy, and MK-3475 (Pembrolizumab) in High-Risk Head and Neck Squamous Cell Carcinoma (HNSCC).

LOCALLY ADVANCED

R0920: Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally Advanced Resected Head and Neck Cancer.

STAGE III-IVB
HN004: Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy with Concurrent Cetuximab in Patients with Stage III-IVB Head and Neck Cancer with a Contraindication to Cisplatin.

SALIVARY GLAND TUMORS

R1008: Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors.

A091404: A Phase II Study of Enzalutamide for Patients with Androgen Receptor Positive Salivary Cancers.